MHRA: response to consultation on Brexit no-deal

The UK is leaving the EU on 29 March 2019. Following consultation on how medicines, medical devices and clinical trials would be regulated in a no-deal scenario, the government yesterday issued updated guidance setting out the UK’s proposed arrangements for this.